Date | Insider | Price | Amount |
---|---|---|---|
8-24-2020 Insider Buy |
Robert Andrew Douglas Director |
$53.88 CAGR » |
$33,136.20 615 shares |
7-22-2020 Insider Buy |
Robert Andrew Douglas Director |
$47.75 CAGR » |
$32,947.50 690 shares |
6-22-2020 Insider Buy |
Robert Andrew Douglas Director |
$48.20 CAGR » |
$33,740.00 700 shares |
Also See: Institutional Holders of GMED
Also See: SEC filings
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 08/25/2020 | |
End date: | 04/17/2024 | |
Start price/share: | $54.84 | |
End price/share: | $51.20 | |
Dividends collected/share: | $0.00 | |
Total return: | -6.64% | |
Average Annual Total Return: | -1.87% | |
Starting investment: | $10,000.00 | |
Ending investment: | $9,334.79 | |
Years: | 3.65 |
GMED Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent GMED insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding GMED
Free GMED Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |